China Resources Boya Bio pharmaceutical Group Co Ltd (300294) — Cash Flow Reinvestment Rate
China Resources Boya Bio pharmaceutical Group Co Ltd (300294) has a Cash Flow Reinvestment Rate of 9.61x as of December 2025, reinvesting CN¥353.75 Million (capex CN¥122.46 Million plus investments CN¥-231.28 Million) from operating cash flow of CN¥36.82 Million. Explore China Resources Boya Bio pharmaceutical capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
China Resources Boya Bio pharmaceutical Group Co Ltd Cash Flow Reinvestment Rate (2009–2025)
Historical reinvestment intensity for China Resources Boya Bio pharmaceutical Group Co Ltd across 15 annual periods. Also explore China Resources Boya Bio pharmaceutical asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for China Resources Boya Bio pharmaceutical Group Co Ltd (2009–2025)
Year-by-year capital reinvestment analysis for China Resources Boya Bio pharmaceutical Group Co Ltd. For live market cap and broader valuation context, see 300294 market cap overview.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 7.52x | CN¥877.77 Million | CN¥116.69 Million | CN¥535.31 Million | ▲ +78.3% |
| 2024 | 4.22x | CN¥1.26 Billion | CN¥299.78 Million | CN¥197.79 Million | ▲ +2560.5% |
| 2023 | 0.16x | CN¥101.75 Million | CN¥641.73 Million | CN¥87.50 Million | ▼ -85.2% |
| 2022 | 1.07x | CN¥638.41 Million | CN¥596.44 Million | CN¥138.41 Million | ▼ -44.0% |
| 2021 | 1.91x | CN¥2.57 Billion | CN¥1.35 Billion | CN¥68.12 Million | ▲ +819.1% |
| 2020 | 0.21x | CN¥149.53 Million | CN¥718.58 Million | CN¥142.51 Million | ▼ -96.5% |
| 2018 | 6.02x | CN¥210.15 Million | CN¥34.90 Million | CN¥113.90 Million | ▲ +198.6% |
| 2016 | 2.02x | CN¥400.80 Million | CN¥198.76 Million | CN¥300.09 Million | ▲ +14.3% |
| 2015 | 1.76x | CN¥259.36 Million | CN¥147.02 Million | CN¥159.37 Million | ▲ +349.0% |
| 2014 | 0.39x | CN¥47.89 Million | CN¥121.88 Million | CN¥47.89 Million | ▲ +6.4% |
| 2013 | 0.37x | CN¥32.90 Million | CN¥89.11 Million | CN¥32.90 Million | ▲ +39.5% |
| 2012 | 0.26x | CN¥24.45 Million | CN¥92.36 Million | CN¥24.45 Million | ▲ +18.1% |
| 2011 | 0.22x | CN¥18.27 Million | CN¥81.53 Million | CN¥18.27 Million | ▼ -84.9% |
| 2010 | 1.48x | CN¥36.65 Million | CN¥24.77 Million | CN¥36.65 Million | ▲ +38.6% |
| 2009 | 1.07x | CN¥55.40 Million | CN¥51.88 Million | CN¥55.40 Million | — |